Intractable hypercalcaemia due to parathyroid hormone-related peptide secretion by a carcinoid tumour

Clinical Endocrinology

Volumn 46, Issue 3, 1997, Pages 373-375

  Mantzoros, Christos S ^a   Suva, Larry J ^a   Moses, Alan C ^a   Spark, Richard ^a,b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b Diabetes Unit   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITONIN; CARBOPLATIN; FLUOROURACIL; FUROSEMIDE; GALLIUM NITRATE; MITHRAMYCIN; OCTREOTIDE; PAMIDRONIC ACID; PARATHYROID HORMONE RELATED PROTEIN; PHOSPHATE;

ADULT; ARTICLE; CARCINOID; CASE REPORT; FEMALE; HUMAN; HYPERCALCEMIA; INTRAVENOUS DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031002224     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1997.1090921.x     Document Type: Article

References (9)

1. Allen, M.B., Shamash, J., Kerr, K.M. & Leitch, A.G. (1989) Hypercalcaemia in atypical bronchial carcinoid tumours. Chest, 96, 1206-1208.
2. Docherty, H.M. & Heath, D.A. (1989) Multiple forms of parathyroid hormone-like protein in a human tumour. Journal of Molecular Endocrinology, 2, 11-20.
3. Heath, D.A. & Docherty, H.M. (1988) Hypercalcaemia of malignancy. Lancet, i, 308-319.
4. Loveridge, N., Kent, G.N., Heath, D.A. & James, E. (1985) Parathyroid Hormone like bioactivity in a patient with severe osteitis fibrosa cystica due to malignancy. Renotropic actions of a tumour extract as assessed by cytochemical bioassay. Clinical Endocrinology, 22, 135-146.
5. Martin, T.J. (1993) Parathyroid hormone related protein. Journal of Internal Medicine, 233, 1-4.
6. Paspaliaris, V., Vargas, S.D., Gillespie, M.T., Williams, E.D., Danks, J.A., Moseley, J.M., Story, M.E., Pennefeather, J.N., Leaver, D.D. & Martin, T.J. (1992) Oestrogen enhancement of the myometrial response to exogenous parathyroid hormone-related protein (PTHrP) and tissue localization of endogenous PTHrP and its mRNA in the virgin rat uterus. Journal of Endocrinology, 134, 415-425.
7. Scherubl, H., Hescheler, J. & Riecken, E.O. (1993) Molecular mechanisms of somatostatin's inhibition of hormone release: participation of voltage-gated calcium channels and G-proteins. Hormone Metabolism Research, 27 (Suppl.), 1-4.
8. Suva, L.J., Winslow, G.A., Wettenhall, R.E.H., Hammonds, R.G., Moseley, J.M., Diefenbach-Jagger, H.D., Rodda, C.P., Kemp, B.E., Rodriguez, H., Chen, E.Y., Hudson, P.J., Martin, T.J. & Wood, W.I. (1987) A parathyroid hormone-related protein implicated in malignant hypercalcaemia: cloning and expression. Science, 237, 893-896.
9. Wynick, D. & Bloom, S.R. (1991) Clinical Review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumours. Journal of Clinical Endocrinology and Metabolism, 73, 1-3